Pediatrix Medical Group, Inc.

Equities

MD

US58502B1061

Healthcare Facilities & Services

Market Closed - Nyse 04:00:01 2024-04-18 pm EDT 5-day change 1st Jan Change
8.81 USD 0.00% Intraday chart for Pediatrix Medical Group, Inc. -6.28% -5.27%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jefferies Cuts Price Target on Pediatrix Medical to $9 From $11, Maintains Hold Rating MT
Deutsche Bank Trims Pediatrix Medical Group Price Target to $8 From $9, Maintains Sell Rating MT
Mizuho Trims Price Target on Pediatrix Medical to $9 From $10, Maintains Neutral Rating MT
Truist Securities Adjusts Price Target on Pediatrix Medical Group to $10 From $10.50, Keeps Hold Rating MT
US Equity Markets Decline Tuesday Ahead of FOMC Meeting Minutes MT
Pediatrix Medical Group Shares Fall After Q4 Adjusted Earnings, Revenue Decline MT
Pediatrix Medical Group, Inc. Provides Earnings Guidance for the Year 2024 CI
Transcript : Pediatrix Medical Group, Inc., Q4 2023 Earnings Call, Feb 20, 2024
North American Morning Briefing : Earnings Back in -2- DJ
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Posts Q4 Revenue $496.4M, vs. Street Est of $523.3M MT
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Reports Q4 EPS $0.32, vs. Street Est of $0.32 MT
Pediatrix Medical Group, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
UBS Initiates Coverage on Pediatrix Medical Group With Neutral Rating, $9.50 Price Target MT
Deutsche Bank Cuts Pediatrix Medical Price Target to $9 From $14, Maintains Sell Rating MT
Transcript : Pediatrix Medical Group, Inc., Q3 2023 Earnings Call, Nov 02, 2023
Tranche Update on Pediatrix Medical Group, Inc. (NYSE:MD)'s Equity Buyback Plan announced on August 2, 2018. CI
Tranche Update on Pediatrix Medical Group, Inc. (NYSE:MD)'s Equity Buyback Plan announced on July 30, 2013. CI
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Reports Q3 Revenue $506.6M, vs. Street Est of $508.3M MT
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Reports Q3 EPS $0.32, vs. Street Est of $0.43 MT
Pediatrix Medical Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Pediatrix Medical Group, Inc., Q2 2023 Earnings Call, Aug 03, 2023
Tranche Update on Pediatrix Medical Group, Inc. (NYSE:MD)'s Equity Buyback Plan announced on July 30, 2013. CI
Tranche Update on Pediatrix Medical Group, Inc. (NYSE:MD)'s Equity Buyback Plan announced on August 2, 2018. CI
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Reports Q2 Revenue $500.6M, vs. Street Est of $495.9M MT
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Posts Q2 EPS $0.39, vs. Street Est of $0.40 MT
Chart Pediatrix Medical Group, Inc.
More charts
Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. Its national network comprises over 2,620 affiliated physicians, including 1,330 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 580 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
8.81 USD
Average target price
9.071 USD
Spread / Average Target
+2.97%
Consensus
  1. Stock Market
  2. Equities
  3. MD Stock
  4. News Pediatrix Medical Group, Inc.
  5. Credit Suisse Adjusts Pediatrix Medical Group's Price Target to $27 From $28, Keeps Outperform Rating